BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24038603)

  • 1. Activation of pluripotency genes by a nanotube-mediated protein delivery system.
    Cho SJ; Choi HW; Cho J; Jung S; Seo HG; Do JT
    Mol Reprod Dev; 2013 Dec; 80(12):1000-8. PubMed ID: 24038603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear reprogramming with a non-integrating human RNA virus.
    Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
    Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.
    Islam SM; Suenaga Y; Takatori A; Ueda Y; Kaneko Y; Kawana H; Itami M; Ohira M; Yokoi S; Nakagawara A
    Cancer Sci; 2015 Oct; 106(10):1351-61. PubMed ID: 26190440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. piggyBac Transposon Mediated Reprogramming and Flow Cytometry Analysis of CD44 and ICAM1 Cell-Surface Marker Changes.
    Brightwell S; Kaji K
    Methods Mol Biol; 2016; 1357():285-93. PubMed ID: 25410291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
    Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
    Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
    Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
    Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
    Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
    Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecules facilitate rapid and synchronous iPSC generation.
    Bar-Nur O; Brumbaugh J; Verheul C; Apostolou E; Pruteanu-Malinici I; Walsh RM; Ramaswamy S; Hochedlinger K
    Nat Methods; 2014 Nov; 11(11):1170-6. PubMed ID: 25262205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing pluripotency in somatic cells from the snow leopard (Panthera uncia), an endangered felid.
    Verma R; Holland MK; Temple-Smith P; Verma PJ
    Theriogenology; 2012 Jan; 77(1):220-8, 228.e1-2. PubMed ID: 22079579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics of induced pluripotency.
    Ralston A; Rossant J
    Reproduction; 2010 Jan; 139(1):35-44. PubMed ID: 19605512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient induction of pluripotent stem cells from granulosa cells by Oct4 and Sox2.
    Mao J; Zhang Q; Ye X; Liu K; Liu L
    Stem Cells Dev; 2014 Apr; 23(7):779-89. PubMed ID: 24083387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives.
    Bernhardt M; Galach M; Novak D; Utikal J
    Biotechnol J; 2012 Jun; 7(6):810-21. PubMed ID: 22589234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
    Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
    Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Oct4-activating compounds that enhance reprogramming efficiency.
    Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Partially Reprogrammed Cells and Fully Reprogrammed iPS Cells by Plasmid Transfection.
    Kim JS; Choi HW; Hong YJ; Do JT
    Methods Mol Biol; 2016; 1357():85-95. PubMed ID: 25476445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.